• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体来源的miR-372-5p通过诱导巨噬细胞极化促进结直肠癌细胞的干性和转移能力。

Exosome-derived miR-372-5p promotes stemness and metastatic ability of CRC cells by inducing macrophage polarization.

作者信息

Shi Xiuru, Wei Ke, Wu Yulun, Mao Lingyu, Pei Wenhao, Zhu Haitao, Shi Yingxiang, Zhang Shiwen, Tao Shuang, Wang Jing, Pang Siyan, Mao Huilan, Wang Wenrui, Yang Qingling, Chen Changjie

机构信息

Anhui Province Key Laboratory of Translational Cancer Research (Bengbu Medical College), Anhui 233030, China.

Department of Biotechnology, Bengbu Medical College, Anhui 233030, China.

出版信息

Cell Signal. 2023 Nov;111:110884. doi: 10.1016/j.cellsig.2023.110884. Epub 2023 Sep 9.

DOI:10.1016/j.cellsig.2023.110884
PMID:37690660
Abstract

Colorectal cancer (CRC) is the most common malignancy in the digestive system, and tumor metastasis is the main cause of death in clinical patients with CRC. It has been shown that exosomes promote phenotypic changes in macrophages and tumor metastasis in the CRC tumor microenvironment. In this study, we used miRNA-seq technology to screen out the highly expressed miR-372-5p among the miRNAs differentially expressed in plasma exosomes of clinical CRC patients. It was found that miR-372-5p highly expressed in HCT116 exosomes could be phagocytosed by macrophages and promote their polarization into M2 macrophages by regulating the PTEN/AKT pathway. Meanwhile, co-culture of CRC cells with conditioned medium (CM) of macrophages enhanced the EMT, stemness and metastasis of CRC cells. Mechanistically, CRC cells exosome-derived miR-372-5p induced polarized M2 macrophages to secrete chemokine C-X-C-Motif Ligand 12 (CXCL12), which activated the WNT/β-catenin pathway to promote the EMT, stemness and metastatic ability of CRC cells. In summary, this study elucidated the molecular mechanism of exosomal miR-372-5p promoting metastasis and stemness in CRC, which may provide new therapeutic targets for CRC metastasis and prognosis assessment.

摘要

结直肠癌(CRC)是消化系统中最常见的恶性肿瘤,肿瘤转移是CRC临床患者死亡的主要原因。研究表明,外泌体可促进CRC肿瘤微环境中巨噬细胞的表型变化和肿瘤转移。在本研究中,我们使用miRNA测序技术从临床CRC患者血浆外泌体中差异表达的miRNA中筛选出高表达的miR-372-5p。研究发现,HCT116外泌体中高表达的miR-372-5p可被巨噬细胞吞噬,并通过调节PTEN/AKT途径促进其极化为M2巨噬细胞。同时,CRC细胞与巨噬细胞条件培养基(CM)共培养可增强CRC细胞的上皮-间质转化(EMT)、干性和转移能力。机制上,CRC细胞来源的外泌体miR-372-5p诱导极化的M2巨噬细胞分泌趋化因子C-X-C基序配体12(CXCL12),激活WNT/β-连环蛋白途径,促进CRC细胞的EMT、干性和转移能力。总之,本研究阐明了外泌体miR-372-5p促进CRC转移和干性的分子机制,这可能为CRC转移和预后评估提供新的治疗靶点。

相似文献

1
Exosome-derived miR-372-5p promotes stemness and metastatic ability of CRC cells by inducing macrophage polarization.外泌体来源的miR-372-5p通过诱导巨噬细胞极化促进结直肠癌细胞的干性和转移能力。
Cell Signal. 2023 Nov;111:110884. doi: 10.1016/j.cellsig.2023.110884. Epub 2023 Sep 9.
2
Exosomal miR-106a-5p from highly metastatic colorectal cancer cells drives liver metastasis by inducing macrophage M2 polarization in the tumor microenvironment.高转移性结直肠癌细胞来源的外泌体 miR-106a-5p 通过诱导肿瘤微环境中巨噬细胞 M2 极化促进肝转移。
J Exp Clin Cancer Res. 2024 Oct 9;43(1):281. doi: 10.1186/s13046-024-03204-7.
3
Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization.结直肠癌细胞来源的外泌体 miR-203a-3p 通过靶向 PTEN 诱导的巨噬细胞极化促进 CRC 转移。
Gene. 2023 Nov 15;885:147692. doi: 10.1016/j.gene.2023.147692. Epub 2023 Aug 9.
4
Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.外泌体包裹的 miRNA 通过增强巨噬细胞的 M2 极化促进结直肠癌 CXCL12/CXCR4 诱导的肝转移。
Cancer Lett. 2020 Apr 1;474:36-52. doi: 10.1016/j.canlet.2020.01.005. Epub 2020 Jan 10.
5
Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.肿瘤来源的外泌体 miR-934 诱导巨噬细胞 M2 极化促进结直肠癌肝转移。
J Hematol Oncol. 2020 Nov 19;13(1):156. doi: 10.1186/s13045-020-00991-2.
6
Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.肿瘤来源的外泌体 microRNA-106b-5p 激活 EMT-癌细胞和 M2 型 TAM 相互作用,促进 CRC 转移。
Mol Ther. 2021 Jun 2;29(6):2088-2107. doi: 10.1016/j.ymthe.2021.02.006. Epub 2021 Feb 9.
7
Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway.结直肠癌细胞来源的外泌体 miR-372-5p 通过 PTEN/AKT/NF-κB/PD-L1 通路诱导结直肠癌免疫逃逸。
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113261. doi: 10.1016/j.intimp.2024.113261. Epub 2024 Sep 30.
8
Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization.肿瘤源性 miR-6794-5p 通过促进 M2 巨噬细胞极化来增强肿瘤生长。
Cell Commun Signal. 2024 Mar 23;22(1):190. doi: 10.1186/s12964-024-01570-5.
9
Tumor cells-derived exosomal circVCP promoted the progression of colorectal cancer by regulating macrophage M1/M2 polarization.肿瘤细胞来源的外泌体 circVCP 通过调节巨噬细胞 M1/M2 极化促进结直肠癌的进展。
Gene. 2023 Jun 20;870:147413. doi: 10.1016/j.gene.2023.147413. Epub 2023 Apr 5.
10
Exosome-transmitted miRNA-335-5p promotes colorectal cancer invasion and metastasis by facilitating EMT via targeting RASA1.外泌体传递的miRNA-335-5p通过靶向RASA1促进上皮-间质转化,从而促进结直肠癌的侵袭和转移。
Mol Ther Nucleic Acids. 2021 Feb 24;24:164-174. doi: 10.1016/j.omtn.2021.02.022. eCollection 2021 Jun 4.

引用本文的文献

1
Cancer stem cells: advances in knowledge and implications for cancer therapy.癌症干细胞:知识进展及其对癌症治疗的影响。
Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.
2
The activation of HAMP promotes colorectal cancer cell proliferation through zinc-mediated upregulation of SMAD4 expression.HAMP的激活通过锌介导的SMAD4表达上调促进结肠癌细胞增殖。
Transl Cancer Res. 2024 Mar 31;13(3):1493-1507. doi: 10.21037/tcr-23-1292. Epub 2024 Mar 20.
3
Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC-A New Opportunity to Predict Therapy Response.
结直肠癌中ABCC4和ABCG2高表达亚群的特征——预测治疗反应的新契机
Cancers (Basel). 2023 Nov 28;15(23):5623. doi: 10.3390/cancers15235623.